The global RSV Vaccine market was valued at 166 million in 2024 and is projected to reach US$ 280 million by 2031, at a CAGR of 7.9% during the forecast period.
Respiratory syncytial virus vaccine, or RSV vaccine, is a vaccine which prevents infection by respiratory syncytial virus.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the RSV Vaccine manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for RSV Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RSV Vaccine. This report contains market size and forecasts of RSV Vaccine in global, including the following market information:
Global RSV Vaccine market revenue, 2020-2025, 2026-2031, ($ millions)
Global RSV Vaccine market sales, 2020-2025, 2026-2031, (K Units)
Global top five RSV Vaccine companies in 2024 (%)
Total Market by Segment:
Global RSV Vaccine market, by Type, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global RSV Vaccine market segment percentages, by Type, 2024 (%)
Clinical I
Clinical II
Clinical III
Preclinical
Being Developed
Global RSV Vaccine market, by Application, 2020-2025, 2026-2031 ($ Millions) & (K Units)
Global RSV Vaccine market segment percentages, by Application, 2024 (%)
Elderly Vaccine
Infant Vaccine
Others
Global RSV Vaccine market, by region and country, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global RSV Vaccine market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RSV Vaccine revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies RSV Vaccine revenues share in global market, 2024 (%)
Key companies RSV Vaccine sales in global market, 2020-2025 (estimated), (K Units)
Key companies RSV Vaccine sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
GSK
Moderna
JNJ
Bavarian Nordic
Nuance Pharma
Advaccine
Outline of Major Chapters:
Chapter 1: Introduces the definition of RSV Vaccine, market overview.
Chapter 2: Global RSV Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of RSV Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of RSV Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global RSV Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 RSV Vaccine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global RSV Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RSV Vaccine Overall Market Size
2.1 Global RSV Vaccine Market Size: 2024 VS 2031
2.2 Global RSV Vaccine Market Size, Prospects & Forecasts: 2020-2031
2.3 Global RSV Vaccine Sales: 2020-2031
3 Company Landscape
3.1 Top RSV Vaccine Players in Global Market
3.2 Top Global RSV Vaccine Companies Ranked by Revenue
3.3 Global RSV Vaccine Revenue by Companies
3.4 Global RSV Vaccine Sales by Companies
3.5 Global RSV Vaccine Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 RSV Vaccine Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers RSV Vaccine Product Type
3.8 Tier 1, Tier 2, and Tier 3 RSV Vaccine Players in Global Market
3.8.1 List of Global Tier 1 RSV Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 RSV Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global RSV Vaccine Market Size Markets, 2024 & 2031
4.1.2 Clinical I
4.1.3 Clinical II
4.1.4 Clinical III
4.1.5 Preclinical
4.1.6 Being Developed
4.2 Segment by Type - Global RSV Vaccine Revenue & Forecasts
4.2.1 Segment by Type - Global RSV Vaccine Revenue, 2020-2025
4.2.2 Segment by Type - Global RSV Vaccine Revenue, 2026-2031
4.2.3 Segment by Type - Global RSV Vaccine Revenue Market Share, 2020-2031
4.3 Segment by Type - Global RSV Vaccine Sales & Forecasts
4.3.1 Segment by Type - Global RSV Vaccine Sales, 2020-2025
4.3.2 Segment by Type - Global RSV Vaccine Sales, 2026-2031
4.3.3 Segment by Type - Global RSV Vaccine Sales Market Share, 2020-2031
4.4 Segment by Type - Global RSV Vaccine Price (Manufacturers Selling Prices), 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global RSV Vaccine Market Size, 2024 & 2031
5.1.2 Elderly Vaccine
5.1.3 Infant Vaccine
5.1.4 Others
5.2 Segment by Application - Global RSV Vaccine Revenue & Forecasts
5.2.1 Segment by Application - Global RSV Vaccine Revenue, 2020-2025
5.2.2 Segment by Application - Global RSV Vaccine Revenue, 2026-2031
5.2.3 Segment by Application - Global RSV Vaccine Revenue Market Share, 2020-2031
5.3 Segment by Application - Global RSV Vaccine Sales & Forecasts
5.3.1 Segment by Application - Global RSV Vaccine Sales, 2020-2025
5.3.2 Segment by Application - Global RSV Vaccine Sales, 2026-2031
5.3.3 Segment by Application - Global RSV Vaccine Sales Market Share, 2020-2031
5.4 Segment by Application - Global RSV Vaccine Price (Manufacturers Selling Prices), 2020-2031
6 Sights by Region
6.1 By Region - Global RSV Vaccine Market Size, 2024 & 2031
6.2 By Region - Global RSV Vaccine Revenue & Forecasts
6.2.1 By Region - Global RSV Vaccine Revenue, 2020-2025
6.2.2 By Region - Global RSV Vaccine Revenue, 2026-2031
6.2.3 By Region - Global RSV Vaccine Revenue Market Share, 2020-2031
6.3 By Region - Global RSV Vaccine Sales & Forecasts
6.3.1 By Region - Global RSV Vaccine Sales, 2020-2025
6.3.2 By Region - Global RSV Vaccine Sales, 2026-2031
6.3.3 By Region - Global RSV Vaccine Sales Market Share, 2020-2031
6.4 North America
6.4.1 By Country - North America RSV Vaccine Revenue, 2020-2031
6.4.2 By Country - North America RSV Vaccine Sales, 2020-2031
6.4.3 United States RSV Vaccine Market Size, 2020-2031
6.4.4 Canada RSV Vaccine Market Size, 2020-2031
6.4.5 Mexico RSV Vaccine Market Size, 2020-2031
6.5 Europe
6.5.1 By Country - Europe RSV Vaccine Revenue, 2020-2031
6.5.2 By Country - Europe RSV Vaccine Sales, 2020-2031
6.5.3 Germany RSV Vaccine Market Size, 2020-2031
6.5.4 France RSV Vaccine Market Size, 2020-2031
6.5.5 U.K. RSV Vaccine Market Size, 2020-2031
6.5.6 Italy RSV Vaccine Market Size, 2020-2031
6.5.7 Russia RSV Vaccine Market Size, 2020-2031
6.5.8 Nordic Countries RSV Vaccine Market Size, 2020-2031
6.5.9 Benelux RSV Vaccine Market Size, 2020-2031
6.6 Asia
6.6.1 By Region - Asia RSV Vaccine Revenue, 2020-2031
6.6.2 By Region - Asia RSV Vaccine Sales, 2020-2031
6.6.3 China RSV Vaccine Market Size, 2020-2031
6.6.4 Japan RSV Vaccine Market Size, 2020-2031
6.6.5 South Korea RSV Vaccine Market Size, 2020-2031
6.6.6 Southeast Asia RSV Vaccine Market Size, 2020-2031
6.6.7 India RSV Vaccine Market Size, 2020-2031
6.7 South America
6.7.1 By Country - South America RSV Vaccine Revenue, 2020-2031
6.7.2 By Country - South America RSV Vaccine Sales, 2020-2031
6.7.3 Brazil RSV Vaccine Market Size, 2020-2031
6.7.4 Argentina RSV Vaccine Market Size, 2020-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa RSV Vaccine Revenue, 2020-2031
6.8.2 By Country - Middle East & Africa RSV Vaccine Sales, 2020-2031
6.8.3 Turkey RSV Vaccine Market Size, 2020-2031
6.8.4 Israel RSV Vaccine Market Size, 2020-2031
6.8.5 Saudi Arabia RSV Vaccine Market Size, 2020-2031
6.8.6 UAE RSV Vaccine Market Size, 2020-2031
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer RSV Vaccine Major Product Offerings
7.1.4 Pfizer RSV Vaccine Sales and Revenue in Global (2020-2025)
7.1.5 Pfizer Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK RSV Vaccine Major Product Offerings
7.2.4 GSK RSV Vaccine Sales and Revenue in Global (2020-2025)
7.2.5 GSK Key News & Latest Developments
7.3 Moderna
7.3.1 Moderna Company Summary
7.3.2 Moderna Business Overview
7.3.3 Moderna RSV Vaccine Major Product Offerings
7.3.4 Moderna RSV Vaccine Sales and Revenue in Global (2020-2025)
7.3.5 Moderna Key News & Latest Developments
7.4 JNJ
7.4.1 JNJ Company Summary
7.4.2 JNJ Business Overview
7.4.3 JNJ RSV Vaccine Major Product Offerings
7.4.4 JNJ RSV Vaccine Sales and Revenue in Global (2020-2025)
7.4.5 JNJ Key News & Latest Developments
7.5 Bavarian Nordic
7.5.1 Bavarian Nordic Company Summary
7.5.2 Bavarian Nordic Business Overview
7.5.3 Bavarian Nordic RSV Vaccine Major Product Offerings
7.5.4 Bavarian Nordic RSV Vaccine Sales and Revenue in Global (2020-2025)
7.5.5 Bavarian Nordic Key News & Latest Developments
7.6 Nuance Pharma
7.6.1 Nuance Pharma Company Summary
7.6.2 Nuance Pharma Business Overview
7.6.3 Nuance Pharma RSV Vaccine Major Product Offerings
7.6.4 Nuance Pharma RSV Vaccine Sales and Revenue in Global (2020-2025)
7.6.5 Nuance Pharma Key News & Latest Developments
7.7 Advaccine
7.7.1 Advaccine Company Summary
7.7.2 Advaccine Business Overview
7.7.3 Advaccine RSV Vaccine Major Product Offerings
7.7.4 Advaccine RSV Vaccine Sales and Revenue in Global (2020-2025)
7.7.5 Advaccine Key News & Latest Developments
8 Global RSV Vaccine Production Capacity, Analysis
8.1 Global RSV Vaccine Production Capacity, 2020-2031
8.2 RSV Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global RSV Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 RSV Vaccine Supply Chain Analysis
10.1 RSV Vaccine Industry Value Chain
10.2 RSV Vaccine Upstream Market
10.3 RSV Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 RSV Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of RSV Vaccine in Global Market
Table 2. Top RSV Vaccine Players in Global Market, Ranking by Revenue (2024)
Table 3. Global RSV Vaccine Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global RSV Vaccine Revenue Share by Companies, 2020-2025
Table 5. Global RSV Vaccine Sales by Companies, (K Units), 2020-2025
Table 6. Global RSV Vaccine Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers RSV Vaccine Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers RSV Vaccine Product Type
Table 9. List of Global Tier 1 RSV Vaccine Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 RSV Vaccine Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type – Global RSV Vaccine Revenue, (US$, Mn), 2024 & 2031
Table 12. Segment by Type - Global RSV Vaccine Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global RSV Vaccine Revenue (US$, Mn), 2026-2031
Table 14. Segment by Type - Global RSV Vaccine Sales (K Units), 2020-2025
Table 15. Segment by Type - Global RSV Vaccine Sales (K Units), 2026-2031
Table 16. Segment by Application – Global RSV Vaccine Revenue, (US$, Mn), 2024 & 2031
Table 17. Segment by Application - Global RSV Vaccine Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global RSV Vaccine Revenue, (US$, Mn), 2026-2031
Table 19. Segment by Application - Global RSV Vaccine Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global RSV Vaccine Sales, (K Units), 2026-2031
Table 21. By Region – Global RSV Vaccine Revenue, (US$, Mn), 2025-2031
Table 22. By Region - Global RSV Vaccine Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global RSV Vaccine Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Global RSV Vaccine Sales, (K Units), 2020-2025
Table 25. By Region - Global RSV Vaccine Sales, (K Units), 2026-2031
Table 26. By Country - North America RSV Vaccine Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America RSV Vaccine Revenue, (US$, Mn), 2026-2031
Table 28. By Country - North America RSV Vaccine Sales, (K Units), 2020-2025
Table 29. By Country - North America RSV Vaccine Sales, (K Units), 2026-2031
Table 30. By Country - Europe RSV Vaccine Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe RSV Vaccine Revenue, (US$, Mn), 2026-2031
Table 32. By Country - Europe RSV Vaccine Sales, (K Units), 2020-2025
Table 33. By Country - Europe RSV Vaccine Sales, (K Units), 2026-2031
Table 34. By Region - Asia RSV Vaccine Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia RSV Vaccine Revenue, (US$, Mn), 2026-2031
Table 36. By Region - Asia RSV Vaccine Sales, (K Units), 2020-2025
Table 37. By Region - Asia RSV Vaccine Sales, (K Units), 2026-2031
Table 38. By Country - South America RSV Vaccine Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America RSV Vaccine Revenue, (US$, Mn), 2026-2031
Table 40. By Country - South America RSV Vaccine Sales, (K Units), 2020-2025
Table 41. By Country - South America RSV Vaccine Sales, (K Units), 2026-2031
Table 42. By Country - Middle East & Africa RSV Vaccine Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa RSV Vaccine Revenue, (US$, Mn), 2026-2031
Table 44. By Country - Middle East & Africa RSV Vaccine Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa RSV Vaccine Sales, (K Units), 2026-2031
Table 46. Pfizer Company Summary
Table 47. Pfizer RSV Vaccine Product Offerings
Table 48. Pfizer RSV Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Pfizer Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK RSV Vaccine Product Offerings
Table 52. GSK RSV Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. GSK Key News & Latest Developments
Table 54. Moderna Company Summary
Table 55. Moderna RSV Vaccine Product Offerings
Table 56. Moderna RSV Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Moderna Key News & Latest Developments
Table 58. JNJ Company Summary
Table 59. JNJ RSV Vaccine Product Offerings
Table 60. JNJ RSV Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. JNJ Key News & Latest Developments
Table 62. Bavarian Nordic Company Summary
Table 63. Bavarian Nordic RSV Vaccine Product Offerings
Table 64. Bavarian Nordic RSV Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. Bavarian Nordic Key News & Latest Developments
Table 66. Nuance Pharma Company Summary
Table 67. Nuance Pharma RSV Vaccine Product Offerings
Table 68. Nuance Pharma RSV Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Nuance Pharma Key News & Latest Developments
Table 70. Advaccine Company Summary
Table 71. Advaccine RSV Vaccine Product Offerings
Table 72. Advaccine RSV Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. Advaccine Key News & Latest Developments
Table 74. RSV Vaccine Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 75. Global RSV Vaccine Capacity Market Share of Key Manufacturers, 2023-2025
Table 76. Global RSV Vaccine Production by Region, 2020-2025 (K Units)
Table 77. Global RSV Vaccine Production by Region, 2026-2031 (K Units)
Table 78. RSV Vaccine Market Opportunities & Trends in Global Market
Table 79. RSV Vaccine Market Drivers in Global Market
Table 80. RSV Vaccine Market Restraints in Global Market
Table 81. RSV Vaccine Raw Materials
Table 82. RSV Vaccine Raw Materials Suppliers in Global Market
Table 83. Typical RSV Vaccine Downstream
Table 84. RSV Vaccine Downstream Clients in Global Market
Table 85. RSV Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. RSV Vaccine Product Picture
Figure 2. RSV Vaccine Segment by Type in 2024
Figure 3. RSV Vaccine Segment by Application in 2024
Figure 4. Global RSV Vaccine Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global RSV Vaccine Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global RSV Vaccine Revenue: 2020-2031 (US$, Mn)
Figure 8. RSV Vaccine Sales in Global Market: 2020-2031 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by RSV Vaccine Revenue in 2024
Figure 10. Segment by Type – Global RSV Vaccine Revenue, (US$, Mn), 2024 & 2031
Figure 11. Segment by Type - Global RSV Vaccine Revenue Market Share, 2020-2031
Figure 12. Segment by Type - Global RSV Vaccine Sales Market Share, 2020-2031
Figure 13. Segment by Type - Global RSV Vaccine Price (US$/Unit), 2020-2031
Figure 14. Segment by Application – Global RSV Vaccine Revenue, (US$, Mn), 2024 & 2031
Figure 15. Segment by Application - Global RSV Vaccine Revenue Market Share, 2020-2031
Figure 16. Segment by Application - Global RSV Vaccine Sales Market Share, 2020-2031
Figure 17. Segment by Application -Global RSV Vaccine Price (US$/Unit), 2020-2031
Figure 18. By Region – Global RSV Vaccine Revenue, (US$, Mn), 2025 & 2031
Figure 19. By Region - Global RSV Vaccine Revenue Market Share, 2020 VS 2024 VS 2031
Figure 20. By Region - Global RSV Vaccine Revenue Market Share, 2020-2031
Figure 21. By Region - Global RSV Vaccine Sales Market Share, 2020-2031
Figure 22. By Country - North America RSV Vaccine Revenue Market Share, 2020-2031
Figure 23. By Country - North America RSV Vaccine Sales Market Share, 2020-2031
Figure 24. United States RSV Vaccine Revenue, (US$, Mn), 2020-2031
Figure 25. Canada RSV Vaccine Revenue, (US$, Mn), 2020-2031
Figure 26. Mexico RSV Vaccine Revenue, (US$, Mn), 2020-2031
Figure 27. By Country - Europe RSV Vaccine Revenue Market Share, 2020-2031
Figure 28. By Country - Europe RSV Vaccine Sales Market Share, 2020-2031
Figure 29. Germany RSV Vaccine Revenue, (US$, Mn), 2020-2031
Figure 30. France RSV Vaccine Revenue, (US$, Mn), 2020-2031
Figure 31. U.K. RSV Vaccine Revenue, (US$, Mn), 2020-2031
Figure 32. Italy RSV Vaccine Revenue, (US$, Mn), 2020-2031
Figure 33. Russia RSV Vaccine Revenue, (US$, Mn), 2020-2031
Figure 34. Nordic Countries RSV Vaccine Revenue, (US$, Mn), 2020-2031
Figure 35. Benelux RSV Vaccine Revenue, (US$, Mn), 2020-2031
Figure 36. By Region - Asia RSV Vaccine Revenue Market Share, 2020-2031
Figure 37. By Region - Asia RSV Vaccine Sales Market Share, 2020-2031
Figure 38. China RSV Vaccine Revenue, (US$, Mn), 2020-2031
Figure 39. Japan RSV Vaccine Revenue, (US$, Mn), 2020-2031
Figure 40. South Korea RSV Vaccine Revenue, (US$, Mn), 2020-2031
Figure 41. Southeast Asia RSV Vaccine Revenue, (US$, Mn), 2020-2031
Figure 42. India RSV Vaccine Revenue, (US$, Mn), 2020-2031
Figure 43. By Country - South America RSV Vaccine Revenue Market Share, 2020-2031
Figure 44. By Country - South America RSV Vaccine Sales, Market Share, 2020-2031
Figure 45. Brazil RSV Vaccine Revenue, (US$, Mn), 2020-2031
Figure 46. Argentina RSV Vaccine Revenue, (US$, Mn), 2020-2031
Figure 47. By Country - Middle East & Africa RSV Vaccine Revenue, Market Share, 2020-2031
Figure 48. By Country - Middle East & Africa RSV Vaccine Sales, Market Share, 2020-2031
Figure 49. Turkey RSV Vaccine Revenue, (US$, Mn), 2020-2031
Figure 50. Israel RSV Vaccine Revenue, (US$, Mn), 2020-2031
Figure 51. Saudi Arabia RSV Vaccine Revenue, (US$, Mn), 2020-2031
Figure 52. UAE RSV Vaccine Revenue, (US$, Mn), 2020-2031
Figure 53. Global RSV Vaccine Production Capacity (K Units), 2020-2031
Figure 54. The Percentage of Production RSV Vaccine by Region, 2024 VS 2031
Figure 55. RSV Vaccine Industry Value Chain
Figure 56. Marketing Channels
